Pregled bibliografske jedinice broj: 227503
Levosimendan as a New Strategy During Off-pump Coronary Artery Bypass Grafting: Double-blind Randomized Placebo-controlled Trial
Levosimendan as a New Strategy During Off-pump Coronary Artery Bypass Grafting: Double-blind Randomized Placebo-controlled Trial // Croatian medical journal, 46 (2005), 6; 950-956 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 227503 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Levosimendan as a New Strategy During Off-pump Coronary Artery Bypass Grafting: Double-blind Randomized Placebo-controlled Trial
Autori
Husedžinović, Ino ; Barišin, Stjepan ; Bradić, Nikola ; Barišin, Ana ; Sonički, Zdenko ; Milanović, Rudolf
Izvornik
Croatian medical journal (0353-9504) 46
(2005), 6;
950-956
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Levosimendan; Off-pump cardiac surgery; hemodynamic
Sažetak
Aim was to determine if levosimendan could improve cardiac performance during off-pump coronary artery bypass grafting in patients with normal preoperative left ventricular function. Twenty-four patients included in this double-blind randomized controlled trial received either placebo (n=12) or 12 g/kg loading dose of levosimendan (n=12) during a period of 15 minutes before the surgery. The heart rate, cardiac index, stroke volume index, and left ventricular ejection fraction were measured before and 10 and 60 minutes after the drug administration. The baseline measurements of hemodynamic parameters did not differ between the groups. Heart rate was not significantly different between the placebo and levosimendan group. Compared with placebo group, cardiac index and left ventricular ejection fraction were significantly higher 10 and 60 minutes (p=0.018 for all) after administration of levosimendan. After 60 minutes, the cardiac index increased from the baseline value of 2.18 L/min/m2 to 2.84 L/min/m2. Left ventricular ejection fraction increased by 14% after 10 minutes, and by 10% after 60 minutes. Stroke volume index was significantly higher at 10 minutes (p=0.018), but not at 60 minutes (p=0.063) after the administration of levosimendan. Administration of 12 g/kg of levosimendan enhances the left ventricular performance and offers a promising therapeutic option during off-pump coronary artery bypass grafting in patients with good preoperative left ventricular function.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0198019
Ustanove:
Klinička bolnica "Dubrava"
Profili:
Ino Husedžinović
(autor)
Nikola Bradić
(autor)
Rudolf Milanović
(autor)
Ana Barišin
(autor)
Stjepan Barišin
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE